Table 1.
Group | ND | D | DGSH15 | DGSH30 |
---|---|---|---|---|
Initial body weight (g) | 26.91±2.97 | 28.52±2.04 | 26.25±1.76 | 29.13±1.11 |
Final body weight (g) | 28.02±1.53 | 26.33±1.64 | 23.03±2.17 | 24.91±1.46 |
Weight gain (%) | 3.9±1.6 | −4.3±6.5 | −6.5±4.6 | −16.3±4.6 |
Left testis (g) | 0.09±0.01 | 0.08±0.04 | 0.08±0.01 | 0.09±0.02 |
Relative left testicular weight (%) | 0.3±0.0 | 0.3±0.1 | 0.4±0.0 | 0.4±0.1 |
Right testis (g) | 0.09±0.01 | 0.08±0.04 | 0.08±0.01 | 0.09±0.01 |
Relative right testicular weight (%) | 0.3±0.0 | 0.3±0.1 | 0.4±0.0 | 0.4±0.0 |
Seminal vesicle (g) | 0.28±0.04 | 0.24±0.16 | 0.13±0.12 | 0.21±0.04 |
Relative seminal vesicle weight (%) | 1.0±0.2 | 0.9±0.5 | 0.6±0.2* | 0.8±0.2* |
Left epididymis (g) | 0.04±0.01 | 0.04±0.02 | 0.04±0.01 | 0.05±0.02 |
Relative left epididymis weight (%) | 0.1±0.0 | 0.2±0.0 | 0.2±0.0 | 0.2±0.1* |
Right epididymis (g) | 0.04±0.01 | 0.04±0.02 | 0.04±0.01 | 0.05±0.01 |
Relative right epididymis weight (%) | 0.1±0.0 | 0.2±0.1 | 0.2±0.0 | 0.2±0.0* |
*P < 0.05, the indicated group compared with ND Group. ND: nondiabetic control group; D: diabetic control group; DGSH15: diabetic mice treated with GSH at 15 mg kg−1 BW; DGSH30: diabetic mice treated with GSH at 30 mg kg−1 BW; GSH: glutathione; BW: body weight